Research output per year
Research output per year
Fingerprint
The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
- 1 Similar Profiles
Collaborations from the last five years
Dive into details by clicking on the dots.
-
Validation of the Khorana score for predicting venous thromboembolism in 40 218 patients with cancer initiating chemotherapy
Overvad, T. F., Ording, A. G., Nielsen, P. B., Skjøth, F., Albertsen, I. E., Noble, S., Krog Vistisen, A., Gade, I. L., Severinsen, M. T., Piazza, G. & Larsen, T. B., 24 May 2022, In: Blood advances. 6, 10, p. 2967-2976 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile29 Citations (Scopus)99 Downloads (Pure) -
Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer: A randomized controlled chemotherapy-free study-NSGO-AVANOVA2/ENGOT-OV24.
Mirza, M. R., Avall-Lundqvist, E., Birrer, M. J., Christensen, R. D., Nyvang, G.-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Knudsen, A. O., Boufercha, L., Staff, S., Vistisen, A. K., Bjorge, L. & Maenpaa, J. U., 20 May 2019, In: Journal of Clinical Oncology. 37, 15, Suppl., 5505.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG
Brady, J. L., Binkley, M. S., Hajj, C., Chelius, M., Chau, K., Balogh, A., Levis, M., Filippi, A. R., Jones, M., Mac Manus, M., Wirth, A., Oguchi, M., Krog Vistisen, A., Andraos, T. Y., Ng, A. K., Aleman, B. M. P., Choi, S. H., Kirova, Y., Hardy, S. & Reinartz, G. & 11 others, , 2019, In: Blood. 133, 3, p. 237-245 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
87 Citations (Scopus) -
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial
Mirza, M. R., Åvall Lundqvist, E., Birrer, M. J., dePont Christensen, R., Nyvang, G.-B., Malander, S., Anttila, M., Werner, T. L., Lund, B., Lindahl, G., Hietanen, S., Peen, U., Dimoula, M., Roed, H., Ør Knudsen, A., Staff, S., Krog Vistisen, A., Bjørge, L., Mäenpää, J. U. & AVANOVA investigators & 1 others, , Oct 2019, In: The Lancet. Oncology. 20, 10, p. 1409-1419 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
198 Citations (Scopus) -
Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A collaborative study on behalf of ILROG
Binkley, M. S., Brady, J. L., Hajj, C., Chelius, M., Chau, K., Balogh, A., Levis, M., Filippi, A. R., Jones, M., Ahmed, S., MacManus, M., Wirth, A., Oguchi, M., Vistisen, A. K., Andraos, T. Y., Ng, A., Aleman, B. M. P., Choi, S. H., Kirova, Y. & Hardy, S. & 12 others, , 1 Jul 2019, In: International Journal of Radiation Oncology, Biology, Physics. 104, 3, p. 522-529 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile16 Citations (Scopus)99 Downloads (Pure)
Press/Media
-
Efter HER2-low-afgørelse: Patologerne er allerede klar til at tage næste skridt
07/07/2024
1 item of Media coverage
Press/Media: Press / Media
-
Cheflæge om kølehætter i kemoterapi: De virker
24/06/2024
1 item of Media coverage
Press/Media: Press / Media
-
Debat: Blodige besparelser
Anders Krogh Vistisen & Toke Kirchberg Nilsson
28/11/2015
1 item of Media coverage
Press/Media: Press / Media